1-2 of 2
Joseph Jabbour
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

ASXL1 mutations are associated with adverse outcomes in european leukemianet (ELN) 2024 favorable risk patients with Acute Myeloid Leukemia (AML) treated with venetoclax (VEN) containing low-intensity therapy (LIT)

Free
Jennifer Marvin-Peek, Courtney DiNardo, Sanam Loghavi, Farhad Ravandi, Gautam Borthakur, Naval Daver, Tapan Kadia, Elias Jabbour, Andrew Dunbar, Guilin Tang, Nicholas Short, Fadi Haddad, Joseph Jabbour, Eitan Kugler, Abhishek Maiti, Ghayas Issa, Koichi Takahashi, Kapil Bhalla, Naveen Pemmaraju, Yesid Alvarado Valero, Koji Sasaki, Elizabeth Shpall, Uday Popat, Jeremy Ramdial, Richard Champlin, Guillermo Garcia-Manero, Hagop Kantarjian, Jayastu Senapati
Journal: Blood
Blood (2025) 146 (Supplement 1): 3399.
https://doi.org/10.1182/blood-2025-3399
Published: 2025
Journal Articles

Treatment intensity may alter the prognostic impact of baseline co-mutations in newly diagnosed FLT3-ITD AML treated with FLT3 inhibitor-based therapy

Free
Sankalp Arora, Jayastu Senapati, Nicholas Short, Musa Yilmaz, Sanam Loghavi, Tapan Kadia, Courtney DiNardo, Gautam Borthakur, Joseph Jabbour, Hannah Goulart, Ghayas Issa, Naveen Pemmaraju, Wei-Ying Jen, Hussein Abbas, Michael Andreeff, Hagop Kantarjian, Guillermo Garcia-Manero, Farhad Ravandi, Naval Daver
Journal: Blood
Blood (2025) 146 (Supplement 1): 3397.
https://doi.org/10.1182/blood-2025-3397
Published: 2025